March 23, 2025 02:13 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Lower representation in Parliament will weaken states' political strength: Stalin at delimitation meeting | Lower representation in Parliament will weaken states' political strength: Stalin at delimitation meeting | MK Stalin hosts mega multi-state meeting on delimitation in Chennai, BJP calls it drama | Cash pile accused Justice Yashwant Varma was named in CBI's FIR for alleged corruption, SC junked it later | London: Heathrow Airport resumes operation after substation fire causes power disruption | Bangladesh interim government not planning to ban Sheikh Hasina's Awami League | Fire at Delhi HC judge's house leads to recovery of unaccounted cash, SC collegium acts | Indian researcher Badar Khan Suri won't be deported from US over alleged Hamas link, orders judge | Donald Trump signs order to start dismantling US Education Department | Finland is world's happiest country, India slightly improves its happiness quotient with 118th position

Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Mar 28, 2024, at 05:26 am

New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Mar 27, 2024, at 06:16 am

Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.

Sanofi appoints Nikhilesh Kalra to lead consumer healthcare business for India, South Asia

Apr 13, 2017, at 03:45 am

Kolkata/Mumbai, Apr 12 (IBNS): Sanofi announced the appointment of Nikhilesh Kalra as the General Manager of its Consumer Healthcare (CHC) business in India and South Asia.

Sanofi, Regeneron announce positive Dupilumab Topline results from two phase 3 trials

Apr 02, 2016, at 04:39 am

Kolkata/Paris, Apr 1 (IBNS) Sanofi and Regeneron Pharmaceuticals, Inc. announced that two placebo-controlled Phase 3 studies evaluating investigation dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD) met their primary endpoints.

Sanofi appoints Suresh Kumar to Executive Committee

May 27, 2015, at 11:43 pm

Paris, May 27 (IBNS): Sanofi on Wednesday announced the appointment of Suresh Kumar as a new member of the Executive Committee, effective June 1, 2015.

Close menu